Cyfuse Biomedical KK (FSE:4892) Total Debt per Share: 円122.18 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FSE:4892 Cyfuse Biomedical KK FSE:4892
52 GF Score
Price 円561.00
GF Value 円2,202.02
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Cyfuse Biomedical KK Total Debt per Share?

Cyfuse Biomedical KK FSE:4892 +0.18% 52 Total Debt per Share is 円122.18 as of Jun. 2026. GuruFocus rates FSE:4892 with a GF Score™ of 52/100 and a GF Value™ of 円2,202.02 (Possible Value Trap). The stock has 5 warning signs investors should review.

円122.18 (As of Jun. 2026)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Cyfuse Biomedical KK's Total Debt Per Share for the quarter that ended in Jun. 2026 was 円122.18.

Cyfuse Biomedical KK Total Debt per Share Historical Data

* Premium members only.

The historical data trend for Cyfuse Biomedical KK's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cyfuse Biomedical KK Total Debt per Share Chart

Cyfuse Biomedical KK Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Debt per Share
Get a 7-Day Free Trial 79.39 116.83 115.66 104.19 136.50

Cyfuse Biomedical KK Quarterly Data
Dec20 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 91.47 140.37 136.50 124.12 122.18
FSE:4892
52GF Score
Cyfuse Biomedical KK FSE:4892
Total Debt per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cyfuse Biomedical KK Total Debt per Share Calculation

Cyfuse Biomedical KK's Total Debt Per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(642.3+669.7)/9.6
=136.50

Cyfuse Biomedical KK's Total Debt Per Share for the quarter that ended in Jun. 2026 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(383.3+849.7)/10.1
=122.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Debt per Share →
What does a Total Debt per Share of 円122.18 mean?
Cyfuse Biomedical KK (FSE:4892) has a Total Debt per Share of 円122.18 as of Jun. 2026. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Cyfuse Biomedical KK and its competitors.
Is Cyfuse Biomedical KK's Total Debt per Share too high?
Cyfuse Biomedical KK's current Total Debt per Share is 円122.18. Overall, Cyfuse Biomedical KK has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cyfuse Biomedical KK's Total Debt per Share compare to ZTS?
Cyfuse Biomedical KK's Total Debt per Share of 円122.18 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Debt per Share for a Drug Manufacturers company?
A good Total Debt per Share depends on the Drug Manufacturers industry context. However, Total Debt per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Debt per Share mean?
A high Total Debt per Share can signal that a stock is expensive relative to its fundamentals. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Cyfuse Biomedical KK and its competitors. Cyfuse Biomedical KK's current Total Debt per Share is 円122.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cyfuse Biomedical KK stock overvalued right now?
Based on GuruFocus' analysis, Cyfuse Biomedical KK (FSE:4892) is currently considered Possible Value Trap. The stock's GF Value™ is 円2,202.02, compared to a current price of 円561.00 — trading 74.5% below its estimated fair value. The current Total Debt per Share is 円122.18. Cyfuse Biomedical KK's overall GF Score™ is 52/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Debt per Share calculated?
Total Debt per Share is calculated from a company's financial statements. For Cyfuse Biomedical KK (FSE:4892), the current Total Debt per Share is 円122.18 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cyfuse Biomedical KK (FSE:4892) Overvalued in 2026?

Based on GuruFocus' analysis, Cyfuse Biomedical KK stock appears to be undervalued. The current stock price of 円561.00 is trading 74.5% below its estimated GF Value™ of 円2,202.02. GuruFocus considers Cyfuse Biomedical KK to be Possible Value Trap.

Key valuation signals for FSE:4892:

  • Total Debt per Share: 円122.18
  • GF Value™: 円2,202.02 vs. price of 円561.00 (74.5% below fair value)
  • GF Score™: 52/100 with 5 warning signs

No single metric tells the full story. See the FSE:4892 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cyfuse Biomedical KK Business Description

Other Exchanges 4892:Japan
Address 3-5-27 Mita, 1st Floor, Sumitomo Real Estate Tokyo Mita South Tower, Minato-ku, Tokyo, JPN, 108-6301
Cyfuse Biomedical KK is engaged in the development, manufacturing, and sales of regenerative medicine-related products. The company focuses on delivering three-dimensional tissues and organs created solely from cells as new 3D cell products to medical fields, including regenerative medicine and drug discovery, through the practical application of three-dimensional cell stacking technology. It is engaged in multifaceted development in the following areas: regenerative medicine, drug discovery support, and the device domain, including the development and sales of 3D cell stacking system equipment, such as bio 3D printers equipped with the company's platform technology.
52GF Score

Get the complete analysis for FSE:4892

Total Debt per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円561.00
Price
円2,202.02
GF Value